Publications found:
36,694
Sort by:
High-Grade Glioma (Oncology) - Drugs in Development, 2021
US$ 2,000.00
High-Grade Glioma (Oncology) - Drugs in Development, 2021 SUMMARY High-Grade Glioma (Oncology) - Drugs in Development, 2021 provides an overview of the High-Grade Glioma pipeline landscape. The report...
April 2021
130 pages
Histamine H1 Receptor (HRH1) - Drugs in Development, 2021
US$ 3,000.00
Histamine H1 Receptor (HRH1) - Drugs in Development, 2021 SUMMARY Histamine H1 Receptor (HRH1) - Drugs in Development, 2021 provides in depth analysis on Histamine H1 Receptor (HRH1) targeted pipeline...
April 2021
80 pages
HIV 1 Integrase (EC 2.7.7.) - Drugs in Development, 2021
US$ 3,000.00
HIV 1 Integrase (EC 2.7.7.) - Drugs in Development, 2021 SUMMARY HIV 1 Integrase (EC 2.7.7.) - Drugs in Development, 2021 provides in depth analysis on HIV 1 Integrase (EC 2.7.7.) targeted pipeline th...
April 2021
45 pages
HSV-1 (Infectious Disease) - Drugs in Development, 2021
US$ 2,000.00
HSV-1 (Infectious Disease) - Drugs in Development, 2021 SUMMARY HSV-1 (Infectious Disease) - Drugs in Development, 2021 provides an overview of the HSV-1 pipeline landscape. The report provides compre...
April 2021
30 pages
HSV-2 (Infectious Disease) - Drugs in Development, 2021
US$ 2,000.00
HSV-2 (Infectious Disease) - Drugs in Development, 2021 SUMMARY HSV-2 (Infectious Disease) - Drugs in Development, 2021 provides an overview of the HSV-2 pipeline landscape. The report provides compre...
April 2021
35 pages
Hypoxia (Respiratory) - Drugs in Development, 2021
US$ 2,000.00
Hypoxia (Respiratory) - Drugs in Development, 2021 SUMMARY Hypoxia (Respiratory) - Drugs in Development, 2021 provides an overview of the Hypoxia pipeline landscape. The report provides comprehensive...
April 2021
35 pages